AI English summary of an SEC filing — figures as filed
UnitedHealth Group said the Board of Directors approved an amendment to the Amended and Restated Bylaws on November 6, 2025, effective as of that date.
Key points
AI summaryUnitedHealth Group said the Board of Directors approved an amendment to the Amended and Restated Bylaws on November 6, 2025, effective as of that date.
The company said the sole purpose of the amendment to the Bylaws is to reflect changes to the company's registered office and registered agent in the State of Delaware.
UnitedHealth Group attached as Exhibit 3.1 a complete copy of the Bylaws, as amended to reflect the changes described in this report, which is the Amended and Restated Bylaws effective as of November 6, 2025.
The company stated the date of the earliest event reported on this Form 8-K as November 6, 2025, and the report was signed on November 13, 2025 by Kuai H. Leong, Senior Deputy General Counsel and Deputy Corporate Secretary.
Summary
AI-writtenAnalysis scope · Filing bodyWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.
Board Approves Amendment to Bylaws on November 6, 2025
UnitedHealth Group said the Board of Directors approved an amendment to the Amended and Restated Bylaws on November 6, 2025, effective as of that date.
Source · Based on the filing body and exhibits
Amendment Reflects Changes to Delaware Registered Office and Registered Agent
The company said the sole purpose of the amendment to the Bylaws is to reflect changes to the company's registered office and registered agent in the State of Delaware.
Source · Based on the filing body and exhibits
Amended Bylaws Attached as Exhibit 3.1
UnitedHealth Group attached as Exhibit 3.1 a complete copy of the Bylaws, as amended to reflect the changes described in this report, which is the Amended and Restated Bylaws effective as of November 6, 2025.
Source · Based on the filing body and exhibits
Form 8-K Event Date November 6, 2025, Signature Date November 13, 2025
The company stated the date of the earliest event reported on this Form 8-K as November 6, 2025, and the report was signed on November 13, 2025 by Kuai H. Leong, Senior Deputy General Counsel and Deputy Corporate Secretary.
Source · Based on the filing body and exhibits
AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.
Original filing
The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.
Loading the filing text…